Human RP105 (CD180) activation kit by CRISPRa

CAT#: GA102758

CD180 CRISPRa kit - CRISPR gene activation of human CD180 molecule

  See Other Versions


Find the corresponding CRISPRi Inhibitor Kit

USD 1,290.00

2 Weeks*

Size
    • 1 kit

Product Images

Frequently bought together (2)
Mouse Anti-Human CD180 (RP105) Purified (25 ug)
    • 25 ug

USD 170.00


qSTAR qPCR primer pairs against Homo sapiens gene CD180
    • 200 reactions

USD 120.00

Other products for "CD180"

Specifications

Product Data
Format 3gRNAs, 1 scramble ctrl and 1 enhancer vector
Symbol CD180
Locus ID 4064
Kit Components

GA102758G1, RP105 gRNA vector 1 in pCas-Guide-GFP-CRISPRa

GA102758G2, RP105 gRNA vector 2 in pCas-Guide-GFP-CRISPRa

GA102758G3, RP105 gRNA vector 3 in pCas-Guide-GFP-CRISPRa

1 CRISPRa-Enhancer vector, SKU GE100056

1 CRISPRa scramble vector, SKU GE100077

Disclaimer The kit is designed based on the best knowledge of CRISPa SAM technology. The efficiency of the activation can be affected by many factors, including nucleosome occupancy status, chromatin structure and the gene expression level of the target, etc.
Reference Data
RefSeq NM_005582
Synonyms LY64; Ly78; RP105
Summary 'CD180 is a cell surface molecule consisting of extracellular leucine-rich repeats (LRR) and a short cytoplasmic tail. The extracellular LRR is associated with a molecule called MD-1 and form the cell surface receptor complex, RP105/MD-1. It belongs to the family of pathogen receptors, Toll-like receptors (TLR). RP105/MD1, by working in concert with TLR4, controls B cell recognition and signaling of lipopolysaccharide (LPS), a membrane constituent of Gram-negative bacteria. [provided by RefSeq, Jul 2008]'

Other Versions

{0} Product Review(s)

0 Product Review(s) Submit review

Be the first one to submit a review

Product Citations

*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.